AU2003278333A1 - Polymorphism in the per3 gene as a indicator in the diagnosis and treatment of circadian rhythm sleep disorders - Google Patents

Polymorphism in the per3 gene as a indicator in the diagnosis and treatment of circadian rhythm sleep disorders

Info

Publication number
AU2003278333A1
AU2003278333A1 AU2003278333A AU2003278333A AU2003278333A1 AU 2003278333 A1 AU2003278333 A1 AU 2003278333A1 AU 2003278333 A AU2003278333 A AU 2003278333A AU 2003278333 A AU2003278333 A AU 2003278333A AU 2003278333 A1 AU2003278333 A1 AU 2003278333A1
Authority
AU
Australia
Prior art keywords
polymorphism
diagnosis
indicator
treatment
sleep disorders
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003278333A
Other versions
AU2003278333A8 (en
Inventor
Simon Archer
Josephine Arendt
Malcolm Von Schantz
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Surrey
Original Assignee
University of Surrey
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0224928A external-priority patent/GB0224928D0/en
Priority claimed from GB0313480A external-priority patent/GB0313480D0/en
Application filed by University of Surrey filed Critical University of Surrey
Publication of AU2003278333A8 publication Critical patent/AU2003278333A8/en
Publication of AU2003278333A1 publication Critical patent/AU2003278333A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Pathology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AU2003278333A 2002-10-25 2003-10-24 Polymorphism in the per3 gene as a indicator in the diagnosis and treatment of circadian rhythm sleep disorders Abandoned AU2003278333A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GB0224928.2 2002-10-25
GB0224928A GB0224928D0 (en) 2002-10-25 2002-10-25 Polymorphism
GB0313480.6 2003-06-11
GB0313480A GB0313480D0 (en) 2003-06-11 2003-06-11 Polymorphism
PCT/GB2003/004602 WO2004038043A2 (en) 2002-10-25 2003-10-24 POLYMORPHISM IN THE Per3 GENE AS A INDICATOR IN THE DIAGNOSIS AND TREATMENT OF CIRCADIAN RHYTHM SLEEP DISORDERS

Publications (2)

Publication Number Publication Date
AU2003278333A8 AU2003278333A8 (en) 2004-05-13
AU2003278333A1 true AU2003278333A1 (en) 2004-05-13

Family

ID=32178881

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003278333A Abandoned AU2003278333A1 (en) 2002-10-25 2003-10-24 Polymorphism in the per3 gene as a indicator in the diagnosis and treatment of circadian rhythm sleep disorders

Country Status (2)

Country Link
AU (1) AU2003278333A1 (en)
WO (1) WO2004038043A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009036257A1 (en) * 2007-09-13 2009-03-19 Vanda Pharmaceuticals, Inc. Prediction of sleep parameter and response to sleep-inducing compound based on per3 vntr genotype

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000075669A1 (en) * 1999-06-08 2000-12-14 Aventis Pharmaceuticals Inc. Screening methods for altering circadian rhythm proteins
WO2002055667A2 (en) * 2001-01-11 2002-07-18 Univ Utah Res Found Identification of an advanced sleep phase syndrome gene in humans

Also Published As

Publication number Publication date
AU2003278333A8 (en) 2004-05-13
WO2004038043A3 (en) 2004-06-24
WO2004038043A2 (en) 2004-05-06

Similar Documents

Publication Publication Date Title
AU2003275029A8 (en) Treatment of patients with multiple sclerosis based on gene expression changes in central nervous system tissues
AU2003264282A1 (en) Phenethanolamine derivatives and their use in the treatment of respiratory diseases
EP1571970A3 (en) Diagnosis and monitoring of diseases
EP1360965A4 (en) Methods of treating diseases in association with decrease in the expression of aop-1 gene or aop-1 and remedies for the diseases
AU2003294355A1 (en) Ca125 gene and its use for diagnostic and therapeutic interventions
AU2003233583A1 (en) Oral lactoferrin in the treatment of respiratory disorders
EP1573045A4 (en) Heart failure gene determination and therapeutic screening
AU2003286285A1 (en) Use of fgf-18 in the diagnosis and treatment of memory disorders
AU2002303261A8 (en) Gene brcc2 and diagnostic and therapeutic uses thereof
HUP0201997A2 (en) Polymorphisms in the human mdr-1 gene and their use in diagnostic and therapeutic applications
AU2003219462A8 (en) Defibrillator/monitor with patient specific treatment algorithms
AU2003294856A1 (en) Use of von tetrahydrobiopterine derivatives in the treatment and nutrition of patients with amino acid metabolic disorders
EP1567644A4 (en) Tissue specific genes and gene clusters
AU2003246592A1 (en) Tumour marker and the use thereof for the diagnosis and treatment of tumour diseases
AU2003278333A1 (en) Polymorphism in the per3 gene as a indicator in the diagnosis and treatment of circadian rhythm sleep disorders
EP1589980A4 (en) Methods of diagnosis and treatment of interstitial lung disease
AU2003298768A1 (en) Ex vivo and in vivo expression of the thrombomodulin gene for the treatment of cardiovascular and peripheral vascular diseases
AU2003245858A1 (en) Uses of ngal-binding substances in the diagnosis and treatment of cancer diseases
AU2003224651A1 (en) Clustering conformational variants of molecules and methods of use thereof
AU2003240253A1 (en) Polymorphisms in the human gene for htr3b and their use in diagnostic and therapeutic applications
AU2003280867A1 (en) Specific haplotypes of the mdr1 gene and their use in diagnosis and therapy
AU2003218601A1 (en) Phox2b polymorphisms as hirschsprung's disease diagnostic markers and methods based thereon
EP1539957A4 (en) Novel diagnostic and therapeutic methods and reagents therefor
AU2003244498A1 (en) Polymorphisms in the human gene for tpmt and their use in diagnostic and therapeutic applications
EP1483407A4 (en) Methods of therapy and diagnosis

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase